|
|
| |
|
|
Medicago completes $2,210,000 non-brokered private placement (August 29, 2008)
|
|
|
MEDICAGO ANNOUNCES 2008 SECOND QUARTER RESULTS (August 28, 2008)
|
|
|
Medicago to participate at prominent U.S. vaccine development conference (August 13, 2008)
|
|
|
Medicago CEO to join the Premier of Quebec, Jean Charest, at International Conference in China (August 5, 2008)
|
|
|
Medicago provides update on milestones achieved (July 30, 2008)
|
|
|
Medicago to Present at the Next Generation Vaccines 2008 Conference (July 17, 2008)
|
|
|
Medicago to evaluate establishment of a pandemic vaccine production facility in France in collaboration with Genopole d'Evry in Paris (July 15, 2008)
|
|
|
Medicago receives contribution from NRC-IRAP for seasonal flu vaccine program (July 3, 2008)
|
|
|
Medicago's H5N1 VLP vaccine demonstrates cross-reactivity against multiple strains of avian flu in key ferret animal model (June 25, 2008)
|
|
|
Medicago announces two presentations at the 2008 AAPS National Biotechnology Conference (June 23, 2008)
|
|
|
Medicago to present at the 2008 BIO International Convention in San Diego, CA (June 16, 2008)
|
|
|
Medicago's H5N1 pandemic flu vaccine effective in key ferret animal model with single dose (June 3, 2008)
|
|
|
Medicago CEO to participate in panel discussion at the World Vaccine Congress Asia 2008 (June 2, 2008)
|
|
|
MEDICAGO UPDATES FOLLOWING ITS ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS (May 30, 2008)
|
|
|
MEDICAGO ANNOUNCES 2008 FIRST QUARTER RESULTS
|
|
|
Medicago announces poster presentation at the IDSA Seasonal and Pandemic Influenza 2008 meeting (May 16, 2008)
|
|
|
Medicago appoints new VP manufacturing (May 7, 2008)
|
|
|
Medicago's presentation at BioFinance 2008 (May 5, 2008)
|
|
|
Medicago and Investissement Québec agree to a decrease in interest payments of Medicago's Bio-Levier loan (April 29, 2008)
|
|
|
Medicago announces 2007 results (April 25, 2008)
|
|
|
Medicago appoints new Chief Financial Officer (April 21, 2008)
|
|
|
Medicago completes cGMP qualification of its manufacturing facility (April 16, 2008)
|
|
|
Medicago earns $0.5 million milestone payment from Fortune 100 Company (April 7, 2008)
|
|
|
Medicago announces stock options grant to Chief Executive Officer (April 1st, 2008)
|
|
|
Medicago's H5N1 VLP vaccine provides protection against multiple strains of avian flu (March 19, 2008)
|
|
|
MEDICAGO INC. COMPLETES $2.6 MILLION NON-BROKERED PRIVATE PLACEMENT (March 14, 2008)
|
|
|
Medicago President and CEO to present today at the Partnering for Global Health Forum 2008 (March11, 2008)
|
|
|
MEDICAGO INTENDS TO COMPLETE NON-BROKERED PRIVATE PLACEMENT OF 2 MILLION DOLLARS (February 22, 2008)
|
|
|
Medicago signs second licensing agreement with Fortune 100 Company (February 7, 2008)
|
|
|
Medicago's Pandemic Flu Vaccine Provides 100% Protection in Mice at Low Doses (January 22, 2008)
|
|
|
Medicago signs collaboration and licensing agreement for therapeutic protein production (December 19, 2007)
|
|
|
Medicago to present at the World Health Organization's Third Meeting on Influenza Vaccines (November 30, 2007)
|
|
|
MEDICAGO ANNOUNCES FISCAL 2007 THIRD QUARTER RESULTS (Nov. 29, 2007)
|
|
|
Medicago Announces Additional Positive Results for its H5N1 Avian Influenza VLP vaccine. Preclinical results demonstrate effectiveness of vaccine even at extremely low doses (November 20, 2007)
|
|
|
Medicago Achieves Positive Preclinical Study Results for Proprietary H5N1 Influenza VLP Vaccine (October 31, 2007)
|
|
|
Medicago announces technological milestone with production of self-assembled Influenza Virus-Like Particles in plants (October 18, 2007)
|
|
|
MEDICAGO ANNOUNCES SECOND QUARTER RESULTS (August 29, 2007)
|
|
|
MEDICAGO ANNOUNCES FIRST QUARTER RESULTS (May 30, 2007)
|
|
|
MEDICAGO INC. COMPLETES A PRIVATE PLACEMENT OF $2,000,000 (May 30, 2007)
|
|
|
MEDICAGO INC. INTENDS TO COMPLETE A PRIVATE PLACEMENT OF APPROXIMATELY $2,000,000 (May 11, 2007)
|
|
|
MEDICAGO ANNOUNCES 2006 RESULTS (April 17, 2007)
|
|
|
MEDICAGO LAUNCHES PRE-CLINICAL STUDY FOR AN INFLUENZA VACCINE - Study highlights innovative vaccine production technology - (January 29, 2007)
|
|
|
Medicago Reports 2006 Third Quarter Results (November 28, 2006)
|
|
|
Medicago Reports Second Quarter Financial and Operating Results (August 30, 2006)
|
|
|
MEDICAGO INC. COMPLETES ITS INITIAL PUBLIC OFFERING FOR GROSS PROCEEDS OF $2,003,834 (August 30, 2006)
|
|
|
Medicago and PBL sign license agreements for PBL's bipartite expression and related technologies (August 8, 2006)
|
|
|
MEDICAGO INC. ANNOUNCES THE FILING OF A FINAL PROSPECTUS IN CONNECTION WITH ITS INITIAL PUBLIC OFFERING (August 2, 2006)
|
|
|
